Immunome, Inc. (IMNM)
24.93
+0.43
(+1.76%)
USD |
NASDAQ |
Feb 10, 16:00
24.93
0.00 (0.00%)
After-Hours: 20:00
Immunome Market Cap : 2.286B for Feb. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Prelude Therapeutics, Inc. | 131.39M |
| Eli Lilly & Co. | 917.28B |
| Relay Therapeutics, Inc. | 1.560B |
| Context Therapeutics, Inc. | 216.38M |
| Moderna, Inc. | 16.41B |
Market Cap Related Metrics
| PS Ratio | 204.18 |
| Price to Book Value | 8.663 |
| Price | 24.93 |
| Earnings Yield | -11.86% |